Day 4 Recap: ACR Convergence 2024 Highlights

RheumNow

J. Pope, D. Liew, A. Sood

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

Dematomyositis

Keck School of Medicine of USC

B. Ngo

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

Toby Maher

68 y/o Asian Female With 4 Months of Recurrent Urticaria: Diagnosis …

RheumNow

P. Teh

Bullous Pemphigoid Updates (2024)

NYU Langone

P. Adotama

Abstract Discussions: Osteoporotic Fractures in Postmenopausal Women…

RheumNow

J. Pope

Steroid Tapering in PMR: What's the Gold Standard?

RheumNow

A. Dua

IgG4-Related Disease: An Introduction

Zachary Wallace

Pulmonary Involvement in Rheumatic Diseases: A Review

Brigham and Women's Hospital

P. Dellaripa

PMR Mimics: PMR vs RA?

RheumNow

R. Spiera

72 y/o Female With Giant Cell Arteritis, Polymyalgia Rheumatica, and…

Vanderbilt University Medical Center (VUMC)

K. Byram

Update in Rheumatology 2023 (Gout, JAK safety in RA, Dermatomyositis…

John Tesser

ATS 2024 Insights: Management Decisions After Early Detection of CTD…

Insights from 2024 ATS Annual Meeting

S. Matson

Dermatomyositis Overview

Masterclasses in Dermatology

J. Merola

2023 Rheumatology Year in Review

RheumNow

J. Cush

Clinical Use and Drug Interactions of Common Supplements in Dermatol…

University of Miami

E. Hadeler

Outcomes of COVID-19 Infection in Patients With Primary Systemic Vas…

ACR Convergence 2021 Coverage

S. Sattui Cortes

Resolution of PMR Signs and Symptoms in Patients Treated with Sarilu…

Robert Spiera

AAD 2024 Insights: Clinical Pearls in Autoimmune Connective Tissue D…

AAD 2024

S. Elman